Search results
Evotec Said to Tap Advisers as Slump Sparks Takeover Fears
Bloomberg· 4 days agoGerman drug developer Evotec SE is speaking to defense advisers after a decline in its share price prompted fears about the company’s vulnerability to a takeover, people with knowledge of the matter said.